等待开盘 04-03 09:30:00 美东时间
+0.030
+1.27%
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 78.95 percent increase over losses of $(0.19) per share from
03-27 05:47
Emory Healthcare successfully performed robotic prostate artery embolization (PAE) and Y-90 radioembolization for liver cancer using Microbot Medical's LIBERTY System, a first-of-its-kind FDA-cleared, single-use robotic platform. The system enhances precision, efficiency, and safety in minimally invasive endovascular procedures, addressing conditions like benign prostatic hyperplasia (BPH) and liver cancer.
03-26 12:30
Microbot Medical publishes ACCESS-PVI pivotal study on LIBERTY system in JVIR Microbot Medical reported that an article on its ACCESS-PVI multicenter feasibility study of the LIBERTY endovascular robotic system was published in the Journal of Vascular and Interventional Radiology. The study was comp
03-24 20:30
Microbot Medical to Present at Roth Annual Growth Conference Microbot Medical will participate in the Roth Annual Growth Conference on March 22-24, 2026 in Laguna Niguel, California. CEO Harel Gadot is scheduled to present in a fireside Q&A at 4:00 pm PT on March 23, 2026. The release is available a
03-17 20:40
Microbot Medical Inc. will present at the Roth Annual Growth Conference on March 22-24, 2026, with CEO Harel Gadot discussing the LIBERTY® Endovascular Robotic System. The live fireside Q&A on March 23 at 4:00 PM PT will highlight the system's unique features and market progress. LIBERTY, the first FDA-cleared, single-use robotic system for endovascular procedures, aims to enhance safety and efficiency. The company plans a full market release in ...
03-17 12:40
Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, commends the American Medical Association's (AMA) expanding efforts to protect health care
03-04 21:34
Microbot Medical Backs AMA Policy to Strengthen Radiation Protections Microbot Medical Inc. issued a statement supporting the American Medical Association’s newly adopted policy to expand protections for healthcare professionals from occupational ionizing radiation exposure. The company said the gui
03-04 21:31
Microbot Medical Inc. announced no business disruption in the U.S. and Israel due to geopolitical events, ensuring employee safety and operational continuity. With FDA clearance, the company is focusing on U.S. market expansion, increasing sales coverage and inventory to meet demand. Preparations for the full launch of the LIBERTY System at the SIR conference in April continue, while monitoring regional tensions to maintain operations and custome...
03-03 14:00
绩优股大爆发!Clarivate大涨近40%,VIR涨超27%,是德科技涨超23%;核心产品试验迎突破性进展,医药股PVLA涨超37%>>
02-25 18:56
Microbot Medical stock jumps after Tampa General adopts its FDA-cleared LIBERTY robotic system ahead of April 2026 launch.
02-25 02:48